ABEONA THERAPEUTICS INC

$ABEO
Institutional coverage

101 13F filers hold $ABEO.

13F holders
101
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

3 holders · Q1 2026

$ABEO is held by 3 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.00%, with an average of 0.00% of portfolio. Largest holder: Citigroup Inc. at 0.00%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 101 · Source: 13F-HR
01
GQG Partners LLC
5.36% of portfolio
3,007,329 sh
02
Wallace Capital Management Inc.
1.00% of portfolio
2,040,000 sh
03
Owen LaRue, LLC
3.79% of portfolio
1,329,899 sh
04
Calton & Associates, Inc.
0.12% of portfolio
1,263,511 sh
05
Kennedy Capital Management LLC
0.12% of portfolio
1,050,095 sh
06
Axa S.a.
957,328 sh
07
State Street
898,438 sh
08
Brightline Capital Management, LLC
877,200 sh
09
Laurion Capital Management LP
0.18% of portfolio
770,000 sh
10
Awm Capital, LLC
0.34% of portfolio
648,942 sh
See all 101 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $ABEO in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $ABEO in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:48 UTC.